Overview
Novartis Venture Fund is a corporate venture capital arm of Novartis, investing in innovative life science companies across North America, Europe, and Israel. The fund focuses on pioneering biotechnology and biopharmaceutical companies developing novel therapeutics and platforms to address unmet patient needs, with over USD 750 million in committed capital. They support ventures from seed to later stages, aiming to drive significant patient benefit and generate superior returns.
Unlock the full profileGet the complete company dossier
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.